Article

Free to breathe

Author(s):

In 2006, the National Lung Cancer Partnership created Free to Breathe, a program that started as a walk to raise awareness and research funding for lung cancer. Today, Free to Breathe has grown into over 30 events across the country, which include run/walks, yogathons and golf tournaments. There's also a national walk week (November 5-11) in which you can pick any day of the week that works for you to walk anywhere in your community at any distance!For those of you in the Dallas area on May 21, some of the CURE team will be waking early to participate in the Free to Breathe 5K run/walk and 1 mile walk at the Oak Point Park and Nature Preserve at 2801 East Spring Creek Parkway in Plano, Texas. Join us, and help bring attention to a disease that is the leading cause of cancer death in the U.S. For more information about the Dallas Free to Breathe or to find an event in your area, check out the website here.The National Lung Cancer Partnership is a nonprofit organization of doctors, researchers, patient advocates and survivors who are devoted to raising awareness of lung cancer, to improving patient education for the disease and to generate funding for research. Since its inception, it has funded over $2.2 million in research and provided patient education to countless people. To learn more about the National Lung Cancer Partnership and the work it is doing, check out the website here.Do you participate in a cancer-related event? Tell us about it so we can spread the word!

Related Videos
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
1 expert is featured in this series.
Dr. Richard “Rick" Winneker
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma
1 expert is featured in this series.
Image of man with grey hair.
Image of woman with blonde hair.
Image of man with grey hair.
Related Content